Vector Science and Therapeutics Corp.
PAIN.V
TSX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | 232.90K | 13.70K | 309.20K | ||
| Gross Profit | -232.90K | -13.70K | -309.20K | ||
| SG&A Expenses | 1.22M | 290.70K | 470.90K | ||
| Depreciation & Amortization | 7.50K | 3.30K | 2.60K | ||
| Other Operating Expenses | 248.00K | -78.20K | -- | ||
| Total Operating Expenses | 1.71M | 229.40K | 782.80K | ||
| Operating Income | -1.71M | -229.40K | -782.80K | ||
| Income Before Tax | -2.59M | -241.10K | -987.80K | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -2.59M | -241.10K | -987.80K | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -2.59M | -241.10K | -987.80K | ||
| EBIT | -1.71M | -229.40K | -782.80K | ||
| EBITDA | -1.70M | -226.20K | -780.10K | ||
| EPS Basic | -0.04 | -0.02 | -0.09 | ||
| Normalized Basic EPS | -0.02 | -0.01 | -0.05 | ||
| EPS Diluted | -0.04 | -0.02 | -0.09 | ||
| Normalized Diluted EPS | -0.02 | -0.01 | -0.05 | ||
| Average Basic Shares Outstanding | 70.14M | 11.59M | 11.47M | ||
| Average Diluted Shares Outstanding | 70.14M | 11.59M | 11.47M | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||